These observations point to the need for careful donor follow-up and mitigation of compounding factors such as hypertension, obesity, and diabetes, as well as IGF-1 levels that may amplify the risk for nephron loss in kidney donors (77). The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.